Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v3.4.0.3
Condensed Balance Sheet - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Current Assets:    
Cash and cash equivalents $ 10,463,654 $ 10,199,440
Marketable securities 14,005,173 13,240,086
Prepaid expenses and other current assets 946,061 1,221,818
Total Current Assets 25,414,888 24,661,344
Security Deposits 30,785 30,785
Equipment, Net 111,335 112,900
Total Assets 25,557,008 24,805,029
Current Liabilities:    
Accounts payable and accrued expenses 3,284,267 2,661,298
Deferred Research and Development Arrangement 506,250 525,000
Other Liabilities 98,308 104,020
Warrant Liabilities 4,459,068 2,739,163
Total Liabilities $ 8,347,893 $ 6,029,481
Commitments and Contingencies (note 14)
Stockholders' Equity:    
Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding
Common stock, par value $0.0001, 500,000,000 authorized shares, 213,173,785 and 197,413,785 issued and outstanding $ 21,317 $ 19,741
Additional paid-in capital 127,055,110 124,490,712
Accumulated other comprehensive loss (1,406) (18,041)
Accumulated deficit (109,865,906) (105,716,864)
Total Stockholders' Equity 17,209,115 18,775,548
Total Liabilities and Stockholders' Equity $ 25,557,008 $ 24,805,029